Back to Trades
Entrada Therapeutics, Inc.
TRDACIK: 0001689375
Follow TRDA
Track Entrada Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.
Entrada Therapeutics, Inc. (TRDA) has recorded 23 insider filings from 12 unique insiders, totaling $13.2M in trading activity (net selling). Insiders have sold $4.7M while purchasing $1.6M. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Doshi Dipal. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$13.2M
Purchases
$1.6M
Sales
$4.7M
Unique Insiders
12
Recent Insider Trades
23 loaded
| Jun 12 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Director, 10% Owner | Other | $0 |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Thistle Mary | Director | Other | $0 |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Chapman Gina | Director | Other | $0 |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Radhakrishnan Maha | Director | Other | $0 |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | Zeiher Bernhardt G | Director | Other | $0 |
| Jun 12 | TRDA Entrada Therapeutics, Inc. | KIM PETER S | Director | Other | $0 |
| May 4 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Sell | $230.0K |
| May 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Sell | $398.8K |
| Mar 6 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $97.9K |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Grant | $0 |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Grant | $0 |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Grant | $0 |
| Mar 3 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Grant | $0 |
| Nov 24 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $261.8K |
| Nov 18 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $1.8M |
| Nov 18 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $1.8M |
| Nov 12 | TRDA Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | Insider | Buy | $1.4M |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Director | Other | $0 |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President & COO | Other | $0 |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research & Develop. | Other | $0 |
| Sep 4 | TRDA Entrada Therapeutics, Inc. | WENTWORTH KORY JAMES | Chief Financial Officer | Other | $0 |
| Jul 11 | TRDA Entrada Therapeutics, Inc. | PARMAR KUSH | Insider | Sell | $202.6K |
| Jul 11 | TRDA Entrada Therapeutics, Inc. | 5AM Ventures V, L.P. | Insider | Sell | $202.6K |
23 filings